Mutations in the SMARCB1 (22q11.23) or LZTR1 (22q11.21) tumor-suppressor genes are present in most patients; however, they are insufficient to cause schwannomatosis and require additional somatic mutations. Here, SMARCB1 is linked to neoplasm.